Density of Conjugated Antibody Determines the Extent of Fc Receptor Dependent Capture of Nanoparticles by Liver Sinusoidal Endothelial Cells.
暂无分享,去创建一个
S. Tenzer | H. Schild | M. Diken | R. Zentel | V. Mailänder | Dominika Hobernik | M. Bros | M. Barz | S. Grabbe | E. Montermann | L. Nuhn | David Paßlick | M. Fichter | Cinja Kappel | Michael Kuske | M. Schinnerer | I. Tubbe | Carolina Medina-Montano | Irina Alberg | Ann-Kathrin Hartmann | Christine Seidl | Christian Leps | Julian Sohl | J. Schunke | Gabor Kuhn | R. Bent | Katharina Haas | Kerstin C. Walzer | Manfred Schmidt | Matthias Bros | Matthias Barz | Meike Schinnerer
[1] T. Kiziltepe,et al. In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma , 2020, Journal of Hematology & Oncology.
[2] Christopher B. Howard,et al. Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting. , 2020, ACS nano.
[3] S. Tenzer,et al. Polymeric Nanoparticles: Polymeric Nanoparticles with Neglectable Protein Corona (Small 18/2020) , 2020 .
[4] S. Tenzer,et al. Polymeric Nanoparticles with Neglectable Protein Corona. , 2020, Small.
[5] Greg M. Thurber,et al. Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio Imaging , 2020, Pharmaceutics.
[6] B. D. De Geest,et al. Zebrafish Embryos Allow Prediction of Nanoparticle Circulation Times in Mice and Facilitate Quantification of Nanoparticle-Cell Interactions. , 2020, Small.
[7] C. Oxvig,et al. Differential Nanoparticle Sequestration by Macrophages and Scavenger Endothelial Cells Visualized In Vivo in Real-Time and at Ultrastructural Resolution. , 2020, ACS nano.
[8] J. Windsor,et al. Lymphatic uptake of liposomes after intraperitoneal administration primarily occurs via the diaphragmatic lymphatics and is dependent on liposome surface properties. , 2019, Molecular pharmaceutics.
[9] S. Dzik. Complement and Coagulation: Cross Talk Through Time. , 2019, Transfusion medicine reviews.
[10] J. Thurman,et al. The role of complement in antibody mediated transplant rejection. , 2019, Molecular immunology.
[11] Peter J. Hogarth,et al. The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease , 2019, Front. Immunol..
[12] Alaaldin M. Alkilany,et al. Ligand density on nanoparticles: A parameter with critical impact on nanomedicine. , 2019, Advanced drug delivery reviews.
[13] S. Kent,et al. Immunological basis for enhanced immunity of nanoparticle vaccines , 2019, Expert review of vaccines.
[14] P. Thordarson,et al. Multivalency in Drug Delivery-When Is It Too Much of a Good Thing? , 2019, Bioconjugate chemistry.
[15] H. Simon,et al. Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation , 2019, Cell Death & Differentiation.
[16] Xiaoyu Liang,et al. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. , 2019, Acta biomaterialia.
[17] The UniProt Consortium,et al. UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..
[18] S. Tenzer,et al. Protein corona–mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses , 2018, Journal of Allergy and Clinical Immunology.
[19] Asad U. Khan,et al. Nanomedicine for anticancer and antimicrobial treatment: an overview. , 2018, IET nanobiotechnology.
[20] Edmund J. Crampin,et al. Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.
[21] Peter Y. Li,et al. Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation. , 2018, ACS nano.
[22] R. Haag,et al. Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse Models. , 2018, ACS nano.
[23] K. Landfester,et al. The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery , 2018, Front. Immunol..
[24] K. Landfester,et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona , 2018, Nature Nanotechnology.
[25] Jun Ling,et al. Polysarcosine-containing copolymers: Synthesis, characterization, self-assembly, and applications , 2018, Progress in Polymer Science.
[26] Hanh Thuy Nguyen,et al. Nanoparticles for dendritic cell-based immunotherapy. , 2018, International journal of pharmaceutics.
[27] Heebeom Koo,et al. Application of click chemistry in nanoparticle modification and its targeted delivery , 2018, Biomaterials Research.
[28] J. Lieberman,et al. A modular platform for targeted RNAi therapeutics , 2018, Nature Nanotechnology.
[29] Stefan Tenzer,et al. Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range. , 2017, Journal of proteome research.
[30] Mauro Ferrari,et al. Contribution of Kupffer cells to liposome accumulation in the liver. , 2017, Colloids and surfaces. B, Biointerfaces.
[31] B. Xing,et al. Photoactivated drug delivery and bioimaging. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[32] A. Khosroushahi,et al. Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors , 2017, Cancer Chemotherapy and Pharmacology.
[33] Piao-ping Hu. Recent Advances in Aptamers Targeting Immune System , 2017, Inflammation.
[34] Murugesan V. S. Rajaram,et al. Mouse Liver Sinusoidal Endothelium Eliminates HIV-Like Particles from Blood at a Rate of 100 Million per Minute by a Second-Order Kinetic Process , 2017, Front. Immunol..
[35] P. ten Dijke,et al. A current perspective on applications of macrocyclic‐peptide‐based high‐affinity ligands , 2016, Biopolymers.
[36] Ian D. McGilvray,et al. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[37] D. Schuppan,et al. Nanoparticles and the immune system: challenges and opportunities. , 2016, Nanomedicine.
[38] Antoine Maruani,et al. Antibody fragments as nanoparticle targeting ligands: a step in the right direction , 2016, Chemical science.
[39] H. Schild,et al. Vaccination with trifunctional nanoparticles that address CD8+ dendritic cells inhibits growth of established melanoma. , 2016, Nanomedicine.
[40] W. Saltzman,et al. Cellular distribution of injected PLGA-nanoparticles in the liver. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[41] P. Sondermann,et al. Harnessing Fc receptor biology in the design of therapeutic antibodies. , 2016, Current opinion in immunology.
[42] Özlem Türeci,et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.
[43] Stefan Tenzer,et al. Label-free quantification in ion mobility–enhanced data-independent acquisition proteomics , 2016, Nature Protocols.
[44] Murugesan V. S. Rajaram,et al. Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cells , 2016, Scientific Reports.
[45] Y. Saeys,et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells , 2016, Nature Communications.
[46] Christopher J. H. Porter,et al. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity , 2015, Nature Reviews Drug Discovery.
[47] Joseph M DeSimone,et al. Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation. , 2015, Nano letters.
[48] D. Schuppan,et al. Cylindrical Brush Polymers with Polysarcosine Side Chains: A Novel Biocompatible Carrier for Biomedical Applications , 2015 .
[49] B. Tomczuk,et al. Current ADC Linker Chemistry , 2015, Pharmaceutical Research.
[50] A. Eychmüller,et al. The distribution and degradation of radiolabeled superparamagnetic iron oxide nanoparticles and quantum dots in mice , 2015, Beilstein journal of nanotechnology.
[51] Gillian Dekkers,et al. IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..
[52] M. Bros,et al. Selective uptake of cylindrical poly(2-oxazoline) brush-antiDEC205 antibody-OVA antigen conjugates into DEC-positive dendritic cells and subsequent T-cell activation. , 2014, Chemistry.
[53] Sébastien Dutreuil. Michael Ruse, The Gaïa hypothesis: science on a pagan planet , 2014, History and Philosophy of the Life Sciences.
[54] R. Luxenhofer,et al. On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s. , 2014, Biomaterials.
[55] B. Mishra,et al. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. , 2014, Carbohydrate polymers.
[56] K. Landfester,et al. Polypeptoid-block-polypeptide copolymers: synthesis, characterization, and application of amphiphilic block Copolypept(o)ides in drug formulations and miniemulsion techniques. , 2014, Biomacromolecules.
[57] K. Landfester,et al. Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[58] P. Kubes,et al. Immune surveillance by the liver , 2013, Nature Immunology.
[59] V. Muzykantov,et al. Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation. , 2013, ACS nano.
[60] Robinson,et al. FcγRIIb on Liver Sinusoidal Endothelium Clears Small Immune Complexes , 2012, The Journal of Immunology.
[61] Ying Y Hey,et al. Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function , 2012, Journal of cellular and molecular medicine.
[62] Jean-Philippe Pignol,et al. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. , 2012, Molecular pharmaceutics.
[63] A. Gruhler,et al. Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1). , 2011, Journal of hepatology.
[64] M. Cragg,et al. Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody , 2011, The Journal of Immunology.
[65] R. Luxenhofer,et al. Polypeptoids from N-Substituted Glycine N-Carboxyanhydrides: Hydrophilic, Hydrophobic, and Amphiphilic Polymers with Poisson Distribution , 2011 .
[66] Karl Fischer,et al. Evaluation of nanoparticle aggregation in human blood serum. , 2010, Biomacromolecules.
[67] W. Heath,et al. The CD8+ dendritic cell subset , 2010, Immunological reviews.
[68] P. Deegen,et al. Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation , 2009, Journal of Virology.
[69] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[70] T. Allen,et al. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[71] Håkan Wallin,et al. Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.
[72] Kjetil H Elvevold,et al. The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor , 2007, Hepatology.
[73] S. Kawakami,et al. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. , 2004, International journal of pharmaceutics.
[74] R. Steinman,et al. In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.
[75] Y. Benjamini,et al. Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.
[76] M. Alderton,et al. Pepsin Digestion of Antibodies to Produce Functional Antigen-Binding Fragments (Fab): A Scientific Fantasy? , 2001 .
[77] J. A. Titus,et al. Fragmentation of immunoglobulin G. , 2001, Current protocols in immunology.
[78] Ghazi Rabihavi. David , 1997 .
[79] J. Hall,et al. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. , 1984, Journal of immunology.
[80] Stefka Tyanova,et al. Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research. , 2018, Methods in molecular biology.
[81] H. Kohler. Natural Antibodies: Next Steps Toward Translational Investigation. , 2017, Methods in molecular biology.
[82] Shann S. Yu. Evaluating Nanoparticle Binding to Blood Compartment Immune Cells in High-Throughput with Flow Cytometry. , 2017, Methods in molecular biology.
[83] H. Maeda,et al. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.
[84] C. Armengol,et al. Role of scavenger receptors in the pathophysiology of chronic liver diseases. , 2013, Critical reviews in immunology.